I-China i-China i-China I-RAPID 2019 - I-NCOV Coronavirus Antign yovavanyo - i-gonono
I-China i-China i-China I-RAPID 2019 - I-NCOV Coronavirus Antigen-I-IgnODEAL:
Ikhithi ye-ICnonobio ekhawulezayo ye-Antign Antign ye-Antign yindlela yokufunyanwa kwe-Covidd - Antigen. I-Anti - 2019 - I-NCOV Monuclonnika i-antiddon idityaniswe kumgca wovavanyo kwaye idityaniswe ne-Colloidal Gold. Umxube emva koko wafudukela i-membrane ngesenzo se-capillary kwaye wasabela ngenye i-anti - i-NCOV Monoclonional anti yoNxweme ukusuka kwindawo yovavanyo.
Ikhithi ye-Akwantign Antigen ye-Akwantign luvavanyo olukhawulezileyo lokufumana i-adoronavirus ye-noves coronavirus SARS - I-Cov - kwimvelaphi yomqala kunye nempumlo yomntu. Ngobungcali kwi-vitro diagostik kuphela
Iimpawu zentsebenzo
I-1. Ubuntununtunu, buqu kunye nokuchaneka kwe-SARS - I-Cov - 2 Uvavanyo lwe-Antigen - I-Anticn - Isiphumo sabonisa uvakalelo lobuhlobo kunye nokuchasana
| Indlela | I-regent yomgangatho weGolide (PCR) | Iziphumo zizonke | ||
| I-SARS - Cov - 2 Uvavanyo lwe-Antign (CovidEn - I-19 AG) | Iziphumo | Ikhanyanisi | Engalunganga | |
| Ikhanyanisi | 87 | 0 | 87 | |
| Engalunganga | 4 | 300 | 304 | |
| Isiphumo sisonke | 60 | 300 | 391 | |
Imvakalelo yesihlobo: 95.60% (95% CI: 88.89% ~ 98.63%)
I-100% (95% (95% CI: 98.78% 100.00%)
Ukuchaneka: 98.98% (95% CI: 97.30% ~ 99.70%)
2. Umda wokufumana (indawo yokuhlala)
Umda wokufunyanwa kwe-SARS - I-Cov - 2 Uvavanyo olukhawulezileyo (Covidn - I-19 AG) ufundwe. Indawo yokuhlala yovavanyo kwi-SARS - I-Cov - Iprotheyini ijikeleze i-0.2 - 0.5ng / i-COV -2 Tcid50/ ml
| Uxinzelelo | Isiphumo / Isiphumo | Ixabiso lokuvumelana |
| I-0.5ng / ml n protein | I-100/11 | I-100% |
| I-5x102 Tcid50/ ml | I-100/11 | I-100% |
3. Umnqamlezo - Indawo yokuhlala:
I-SARS - I-Cov - 2 Uvavanyo lwe-Antigen (Covidn - I-19 AG) inxulumene nephaneli yeproteni ye-coronavirsus iphinda iphinde ibuye i-adobinions kunye nezinye iimpawu zokuphefumla. Iziphumo zibonakalise kwiphepha elingaphantsi:
| Into | Uxinzelelo | Isiphumo |
| I-SARS - Cov - 2 n protein | 0.001μg / ml | Ikhanyanisi |
| I-SARS - I-Cov N Iprotein | 1μg / ml | engalunganga |
| I-MERS - I-Cov N Iprotein | 1μg / ml | engalunganga |
| I-HCOV - NL63 n prothein | 1μg / ml | engalunganga |
| I-HCOV - 229e n protein | 1μg / ml | engalunganga |
| I-HCOV - Hku1 n protein | 1μg / ml | engalunganga |
| Intsholongwane yeParaminFluenza | I-1x105Tcid50/ ml | engalunganga |
| Umkhuhlane intsholongwane | I-1x105Tcid50/ ml | engalunganga |
| Intsholongwane ye-Fefluenza b | I-1x105Tcid50/ ml | engalunganga |
| Chmmydia pneumoniae | I-1x105Tcid50/ ml | engalunganga |
| Adenovirus | I-1x105Tcid50/ ml | engalunganga |
| I-Mycoplasma pneumoniae | I-1x105Tcid50/ ml | engalunganga |
| Intsholongwane ebangela usuleleko lwamalungu okuphefumla | I-1x105Tcid50/ ml | engalunganga |
Izinto zokufundisa:
Ezi zinto zilandelayo zivavanywe usebenzisa i-SARS - I-Cov - 2 Uvavanyo olukhawulezileyo (Covidn - 19 AG) kwaye akukho nto yaqwalaselwa.
Into | Uxinzelelo | Isiphumo |
Alpha - I-Eardphon | 3millinguu | Akukho nto iphazamisayo |
I-mucin ecocekileyo | I-1000ng / ml | Akukho nto iphazamisayo |
Igunyazisiwe iziqinisekiso
I-1. I-CE / ISO13485 / Uluhlu oluMhlophe
2. Ibhaliswe eJamani iSebe lezeMpilo
Inkqubo yovavanyo
Imiboniso yeMveliso:
Isikhokelo seMveliso eDibeneyo:
Ngama-nye malungu avela kwi-Ofisi yethu yeNgeniso yeNgeniso yeRhafu yokuxabiseka kwabathengi abafunwayo kunye neShishi lonxibelelwano lweSchina i-Ofchina i-Frit I-PRCRE PRCR Vrcr Vrcle i-PRCR Vrcr i - I-RAPID 2019 - I-NCOV Coronavirsus Antigen - i-MUFON, imveliso iya kubonelela kwihlabathi liphela, njenge: ESan Francisco, ngoku sisemandleni, ngoku sihlakulela abathengisi abaninzi baphesheya, enjalo ngoku njengabo ngeVirginia. Sikhumbula ngokukhuselekileyo ukuba i-merchandise malunga nomatshini wePhepha le-T SORT ihlala ilunge kwinani elikhulu lokufumana umgangatho wakhe olungileyo kwaye likwanjalo neendleko.